» Articles » PMID: 20876178

Cumulative Effective Doses from Radiologic Procedures for Pediatric Oncology Patients

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2010 Sep 30
PMID 20876178
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our aim was to estimate the cumulative effective doses (CEDs) from radiologic procedures for a cohort of pediatric oncology patients.

Methods: A retrospective cohort study of the imaging histories of 150 pediatric oncology patients (30 each in 5 subgroups, that is, leukemia, lymphomas, brain tumors, neuroblastomas, and assorted solid tumors) for 5 years after diagnosis was performed. All procedures involving ionizing radiation were recorded, including radiography, computed tomography (CT), nuclear medicine (NM) studies, fluoroscopy, and interventional procedures. CED estimates were calculated.

Results: Individual CED estimates ranged from <1 mSv to 642 mSv, with a median of 61 mSv. CT and NM were the greatest contributors; CT constituted 30% of procedures but 52% of the total CED, and NM constituted 20% and 46%, respectively. There was considerable variability between tumor subgroups. CED estimates were highest in the neuroblastoma (median: 213 mSv [range: 36-489 mSv]) and lymphoma (median: 191 mSv [range: 10-642 mSv]) groups and lowest in the leukemia group (median: 5 mSv [range: 0.2-57 mSv]).

Conclusions: CEDs from diagnostic and interventional imaging for pediatric oncology patients vary considerably according to diagnoses, individual clinical courses, and imaging modalities used. Increased awareness may promote strategies to reduce the radiation burden to this population.

Citing Articles

International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.

Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A Nat Rev Endocrinol. 2024; 20(12):729-748.

PMID: 39147856 DOI: 10.1038/s41574-024-01024-5.


Validation of Deep Learning-based Augmentation for Reduced F-FDG Dose for PET/MRI in Children and Young Adults with Lymphoma.

Theruvath A, Siedek F, Yerneni K, Muehe A, Spunt S, Pribnow A Radiol Artif Intell. 2021; 3(6):e200232.

PMID: 34870211 PMC: 8637226. DOI: 10.1148/ryai.2021200232.


Factors affecting high cumulative radiation exposure from paediatric computed tomography.

Tangsiwong T, Phewplung T, Trinavarat P Pol J Radiol. 2021; 86:e455-e460.

PMID: 34429793 PMC: 8369816. DOI: 10.5114/pjr.2021.108352.


Evaluation of whole-body MRI with diffusion-weighted sequences in the staging of pediatric cancer patients.

de Oliveira A, de Souza G, Guimaraes C, Guimaraes M, da Costa C, de Gobbi Porto F PLoS One. 2020; 15(8):e0238166.

PMID: 32853252 PMC: 7451574. DOI: 10.1371/journal.pone.0238166.


Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.

Theruvath A, Siedek F, Muehe A, Garcia-Diaz J, Kirchner J, Martin O Radiology. 2020; 296(1):143-151.

PMID: 32368961 PMC: 7325702. DOI: 10.1148/radiol.2020192508.